Walleye Capital
SGRY icon

Walleye Capital’s Surgery Partners SGRY Stock Holding History

Walleye Capital’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.3K Buy
3,529
+367
+12% +$5.15K ﹤0.01% 4121
2026
Q1 		$37.7K Sell
3,162
-368,833
-99% -$5.29M ﹤0.01% 3962
2025
Q4 		$5.75M Sell
371,995
-91,352
-20% -$1.68M 0.02% 1044
2025
Q3 		$10M Buy
463,347
+115,240
+33% +$2.57M 0.04% 549
2025
Q2 		$7.74M Buy
348,107
+202,599
+139% +$4.5M 0.03% 622
2025
Q1 		$3.46M Sell
145,508
-244,992
-63% -$5.8M 0.02% 1035
2024
Q4 		$8.27M Sell
390,500
-108,894
-22% -$2.86M 0.02% 758
2024
Q3 		$16.1M Buy
499,394
+108,031
+28% +$3.19M 0.03% 432
2024
Q2 		$9.31M Buy
391,363
+45,128
+13% +$1.16M 0.02% 810
2024
Q1 		$10.3M Buy
346,235
+34,970
+11% +$1.09M 0.02% 811
2023
Q4 		$9.96M Buy
311,265
+271,779
+688% +$7.89M 0.02% 673
2023
Q3 		$1.15M Buy
+39,486
New +$1.42M ﹤0.01% 2154
2021
Q4 		– Sell
-6,370
Closed -$270K – 2292
2021
Q3 		$270K Buy
+6,370
New +$325K 0.01% 1062

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KSCM
King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Walleye Capital's SGRY Position: Q2 2026 in Review

Walleye Capital increased its Surgery Partners (SGRY) stake by 12% in Q2 2026, buying an estimated $5.15K and bringing the position to 3,529 shares worth $59.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4121.

Walleye Capital first reported a position in SGRY in Q3 2021 and has held it in 13 quarters since. The position peaked at $16.1M in Q3 2024. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Walleye Capital held 3,529 shares of Surgery Partners worth $59.3K as of Q2 2026.
  • Walleye Capital bought 367 Surgery Partners shares in Q2 2026, an estimated $5.15K.
  • Surgery Partners made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4121 holding.
  • Walleye Capital first reported a position in Surgery Partners in Q3 2021 and has held it in 13 quarters since.
  • Walleye Capital's Surgery Partners position peaked at $16.1M in Q3 2024.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.